Fulgent Genetics Inc

NASDAQ:FLGT  
40.64
+4.13 (+11.31%)
Positive Earnings Pre-Announcement

Fulgent Genetics Raises Full Year 2020 Rev Guidance by $100 Mln

Published: 11/09/2020 22:37 GMT
Fulgent Genetics Inc (FLGT) - Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million.
Q3 Non-GAAP Earnings per Share $2.08.
Q3 GAAP Earnings per Share $1.98.
Sees FY 2020 Revenue $235 Million.
Q3 Revenue $101.7 Million.
Q3 Revenue Estimate $48.5 Million -- Refinitiv Ibes Data (analyst estimates).
Sees Q4 2020 Revenue at Least $110 Million.
Q3 Earnings per Share Estimate $0.55 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $158.5 Million
Adjusted EPS is expected to be $3.08

Next Quarter Revenue Guidance is expected to be $143.81 Million
Next Quarter EPS Guidance is expected to be $2.35

More details on our Analysts Page.